|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.30 | 89.11 | 103.69 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Hospital & Healthcare Services
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
722.00
|
|
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 10.76 | 28.74 | 22.65 | 15.01 | 18.04 | CEPS(Rs) | 17.20 | 34.12 | 26.64 | 18.71 | 20.78 | DPS(Rs) | 18.00 | 15.00 | 25.00 | 5.00 | 20.00 | Book NAV/Share(Rs) | 97.59 | 97.78 | 83.70 | 70.88 | 85.59 | Tax Rate(%) | 29.73 | 26.68 | 25.74 | 29.18 | 35.16 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 23.50 | 41.23 | 36.00 | 41.83 | 40.01 | EBIT Margin(%) | 17.60 | 37.48 | 34.15 | 28.26 | 39.79 | Pre Tax Margin(%) | 16.67 | 36.93 | 34.01 | 27.93 | 39.66 | PAT Margin (%) | 11.71 | 27.08 | 25.25 | 19.78 | 25.72 | Cash Profit Margin (%) | 18.72 | 32.15 | 29.70 | 24.65 | 29.63 | Performance Ratios | | | | | | ROA(%) | 8.16 | 24.42 | 25.38 | 17.30 | 19.61 | ROE(%) | 11.02 | 31.68 | 29.32 | 19.20 | 21.09 | ROCE(%) | 16.44 | 43.57 | 39.32 | 27.17 | 32.39 | Asset Turnover(x) | 0.70 | 0.90 | 1.01 | 0.87 | 0.76 | Sales/Fixed Asset(x) | 1.86 | 2.57 | 2.66 | 2.59 | 2.76 | Working Capital/Sales(x) | 3.00 | 3.29 | 3.96 | 6.41 | 4.23 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 0.54 | 0.39 | 0.38 | 0.39 | 0.36 | Receivable days | 66.06 | 44.55 | 22.89 | 11.94 | 9.84 | Inventory Days | 19.23 | 15.07 | 15.64 | 15.49 | 15.79 | Payable days | 41.49 | 38.03 | 45.68 | 39.87 | 19.16 | Valuation Parameters | | | | | | PER(x) | 39.92 | 26.92 | 39.86 | 33.01 | 29.41 | PCE(x) | 24.98 | 22.67 | 33.89 | 26.49 | 25.53 | Price/Book(x) | 4.40 | 7.91 | 10.79 | 6.99 | 6.20 | Yield(%) | 4.19 | 1.94 | 2.77 | 1.01 | 3.77 | EV/Net Sales(x) | 4.64 | 7.27 | 10.05 | 6.51 | 7.54 | EV/Core EBITDA(x) | 18.87 | 17.08 | 26.04 | 14.74 | 17.26 | EV/EBIT(x) | 26.38 | 19.39 | 29.43 | 23.04 | 18.95 | EV/CE(x) | 3.40 | 5.57 | 9.29 | 6.06 | 5.74 | M Cap / Sales | 4.68 | 7.29 | 10.07 | 6.53 | 7.56 | Growth Ratio | | | | | | Net Sales Growth(%) | -13.37 | 18.40 | 18.25 | 8.31 | 11.60 | Core EBITDA Growth(%) | -49.91 | 30.55 | 3.29 | 9.51 | -0.51 | EBIT Growth(%) | -59.32 | 29.96 | 42.91 | -23.08 | -0.69 | PAT Growth(%) | -62.53 | 26.95 | 51.00 | -16.71 | -0.83 | EPS Growth(%) | -62.55 | 26.88 | 50.91 | -16.77 | 0.90 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Current Ratio(x) | 2.10 | 1.81 | 2.91 | 2.23 | 4.57 | Quick Ratio(x) | 1.92 | 1.69 | 2.56 | 1.87 | 3.93 | Interest Cover(x) | 18.86 | 68.33 | 245.36 | 85.85 | 313.47 | Total Debt/Mcap(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|
|
|
|